APA Alıntı

Shen, W., Bièche, I., Fuhrmann, L., Vacher, S., Vincent-Salomon, A., Torrino, S., & Lamaze, C. (2020). EHD2 is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma. Sci Rep.

Chicago Stili Alıntı

Shen, Wei-Wei, Ivan Bièche, Laetitia Fuhrmann, Sophie Vacher, Anne Vincent-Salomon, Stéphanie Torrino, ve Christophe Lamaze. "EHD2 Is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma." Sci Rep 2020.

MLA Alıntı

Shen, Wei-Wei, et al. "EHD2 Is a Predictive Biomarker of Chemotherapy Efficacy in Triple Negative Breast Carcinoma." Sci Rep 2020.